Dr. Lal PathLabs strengthens its genomics capabilities with Illumina's NovaSeq X Series
The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
This collaboration ensures that patients receive comprehensive care, including emotional and psychological support throughout their fertility journey
First and only TROP2-directed therapy approved in the US for the treatment of lung cancer
The program will start with providing bTrastuzumab to cancer patients facing treatment delays due to budget constraints
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
Now approved for both acute and chronic HCV in adults and children aged 3 and above
Ranks among the top 15% companies globally
Dilip Shanghvi to continue as the Executive Chairman of the Board
Subscribe To Our Newsletter & Stay Updated